nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—ALB—Crohn's disease	0.35	1	CbGaD
Losartan—SLCO1B1—Sulfasalazine—Crohn's disease	0.124	0.396	CbGbCtD
Losartan—CYP3A5—Sulfasalazine—Crohn's disease	0.0545	0.174	CbGbCtD
Losartan—ALB—Prednisone—Crohn's disease	0.0542	0.173	CbGbCtD
Losartan—CYP2C19—Prednisone—Crohn's disease	0.0351	0.112	CbGbCtD
Losartan—ABCB1—Prednisone—Crohn's disease	0.0283	0.0906	CbGbCtD
Losartan—CYP3A4—Prednisone—Crohn's disease	0.017	0.0543	CbGbCtD
Losartan—UGT2B17—epithelium—Crohn's disease	0.0106	0.173	CbGeAlD
Losartan—UGT2B17—digestive system—Crohn's disease	0.00809	0.132	CbGeAlD
Losartan—SLC22A12—digestive system—Crohn's disease	0.00521	0.0849	CbGeAlD
Losartan—UGT1A10—digestive system—Crohn's disease	0.00457	0.0745	CbGeAlD
Losartan—Angiitis necrotising—Prednisone—Crohn's disease	0.00378	0.025	CcSEcCtD
Losartan—Stiffness—Mesalazine—Crohn's disease	0.00343	0.0227	CcSEcCtD
Losartan—Vasculitis necrotising—Prednisone—Crohn's disease	0.00329	0.0218	CcSEcCtD
Losartan—UGT1A3—digestive system—Crohn's disease	0.00322	0.0525	CbGeAlD
Losartan—ALB—gall bladder—Crohn's disease	0.00269	0.0438	CbGeAlD
Losartan—Hyperuricaemia—Mercaptopurine—Crohn's disease	0.00259	0.0172	CcSEcCtD
Losartan—Blood uric acid increased—Mercaptopurine—Crohn's disease	0.00245	0.0162	CcSEcCtD
Losartan—ACE—mouth—Crohn's disease	0.00229	0.0373	CbGeAlD
Losartan—SLC2A9—lymph node—Crohn's disease	0.00205	0.0333	CbGeAlD
Losartan—Nephritis interstitial—Mesalazine—Crohn's disease	0.00193	0.0128	CcSEcCtD
Losartan—UGT2B7—digestive system—Crohn's disease	0.00185	0.0301	CbGeAlD
Losartan—AGTR1—epithelium—Crohn's disease	0.0018	0.0294	CbGeAlD
Losartan—Gastric irritation—Prednisone—Crohn's disease	0.00178	0.0118	CcSEcCtD
Losartan—AGTR1—smooth muscle tissue—Crohn's disease	0.00174	0.0283	CbGeAlD
Losartan—Tubulointerstitial nephritis—Mesalazine—Crohn's disease	0.0017	0.0113	CcSEcCtD
Losartan—Jaundice cholestatic—Azathioprine—Crohn's disease	0.00163	0.0108	CcSEcCtD
Losartan—Breast disorder—Mercaptopurine—Crohn's disease	0.00158	0.0104	CcSEcCtD
Losartan—UGT1A1—digestive system—Crohn's disease	0.00157	0.0256	CbGeAlD
Losartan—Jaundice cholestatic—Mesalazine—Crohn's disease	0.00148	0.00983	CcSEcCtD
Losartan—Pancreatitis—Mercaptopurine—Crohn's disease	0.00148	0.00979	CcSEcCtD
Losartan—Vasculitis—Azathioprine—Crohn's disease	0.00147	0.00972	CcSEcCtD
Losartan—Musculoskeletal stiffness—Mesalazine—Crohn's disease	0.00145	0.00963	CcSEcCtD
Losartan—Trauma—Prednisone—Crohn's disease	0.00145	0.0096	CcSEcCtD
Losartan—Gout—Mesalazine—Crohn's disease	0.0014	0.00925	CcSEcCtD
Losartan—AGTR1—lymphoid tissue—Crohn's disease	0.00139	0.0226	CbGeAlD
Losartan—Aplastic anaemia—Azathioprine—Crohn's disease	0.00134	0.00891	CcSEcCtD
Losartan—ACE—epithelium—Crohn's disease	0.00133	0.0217	CbGeAlD
Losartan—Musculoskeletal pain—Mesalazine—Crohn's disease	0.00132	0.00875	CcSEcCtD
Losartan—Epigastric discomfort—Prednisone—Crohn's disease	0.00131	0.00869	CcSEcCtD
Losartan—SLCO1B1—digestive system—Crohn's disease	0.00131	0.0213	CbGeAlD
Losartan—ACE—smooth muscle tissue—Crohn's disease	0.00128	0.0209	CbGeAlD
Losartan—Skin exfoliation—Mesalazine—Crohn's disease	0.00124	0.00825	CcSEcCtD
Losartan—Blood urea increased—Mesalazine—Crohn's disease	0.00123	0.00816	CcSEcCtD
Losartan—Aplastic anaemia—Mesalazine—Crohn's disease	0.00122	0.00811	CcSEcCtD
Losartan—Ecchymosis—Mesalazine—Crohn's disease	0.00118	0.00781	CcSEcCtD
Losartan—ACE—mammalian vulva—Crohn's disease	0.00116	0.0188	CbGeAlD
Losartan—Photosensitivity—Mesalazine—Crohn's disease	0.00108	0.00714	CcSEcCtD
Losartan—Alopecia—Mercaptopurine—Crohn's disease	0.00107	0.00707	CcSEcCtD
Losartan—ACE—lymphoid tissue—Crohn's disease	0.00103	0.0167	CbGeAlD
Losartan—Libido decreased—Mesalazine—Crohn's disease	0.00102	0.00676	CcSEcCtD
Losartan—ACE—digestive system—Crohn's disease	0.00101	0.0165	CbGeAlD
Losartan—Atrial fibrillation—Mesalazine—Crohn's disease	0.000999	0.00662	CcSEcCtD
Losartan—Renal impairment—Mesalazine—Crohn's disease	0.000994	0.00659	CcSEcCtD
Losartan—Arthritis—Mesalazine—Crohn's disease	0.000974	0.00645	CcSEcCtD
Losartan—Anaemia—Mercaptopurine—Crohn's disease	0.000971	0.00643	CcSEcCtD
Losartan—Leukopenia—Mercaptopurine—Crohn's disease	0.00094	0.00623	CcSEcCtD
Losartan—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.000939	0.00622	CcSEcCtD
Losartan—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.000936	0.0062	CcSEcCtD
Losartan—Migraine—Mesalazine—Crohn's disease	0.000932	0.00617	CcSEcCtD
Losartan—Face oedema—Mesalazine—Crohn's disease	0.000914	0.00606	CcSEcCtD
Losartan—Arthralgia—Mercaptopurine—Crohn's disease	0.000894	0.00593	CcSEcCtD
Losartan—Blood creatinine increased—Mesalazine—Crohn's disease	0.000887	0.00588	CcSEcCtD
Losartan—Pancreatitis—Azathioprine—Crohn's disease	0.00088	0.00584	CcSEcCtD
Losartan—Memory impairment—Prednisone—Crohn's disease	0.000879	0.00582	CcSEcCtD
Losartan—Dry skin—Mesalazine—Crohn's disease	0.000867	0.00575	CcSEcCtD
Losartan—Orthostatic hypotension—Mesalazine—Crohn's disease	0.000864	0.00573	CcSEcCtD
Losartan—Oedema—Mercaptopurine—Crohn's disease	0.000857	0.00568	CcSEcCtD
Losartan—Breast disorder—Mesalazine—Crohn's disease	0.000855	0.00567	CcSEcCtD
Losartan—CYP2C19—digestive system—Crohn's disease	0.000853	0.0139	CbGeAlD
Losartan—Cramp muscle—Mesalazine—Crohn's disease	0.000852	0.00565	CcSEcCtD
Losartan—Glycosuria—Prednisone—Crohn's disease	0.000851	0.00564	CcSEcCtD
Losartan—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000839	0.00556	CcSEcCtD
Losartan—Gastritis—Mesalazine—Crohn's disease	0.000838	0.00555	CcSEcCtD
Losartan—Influenza—Mesalazine—Crohn's disease	0.000818	0.00542	CcSEcCtD
Losartan—Anorexia—Mercaptopurine—Crohn's disease	0.000817	0.00541	CcSEcCtD
Losartan—Eosinophilia—Mesalazine—Crohn's disease	0.00081	0.00537	CcSEcCtD
Losartan—Pneumonia—Azathioprine—Crohn's disease	0.000805	0.00534	CcSEcCtD
Losartan—Pancreatitis—Mesalazine—Crohn's disease	0.000802	0.00532	CcSEcCtD
Losartan—Angina pectoris—Mesalazine—Crohn's disease	0.000797	0.00528	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000794	0.00526	CcSEcCtD
Losartan—Bronchitis—Mesalazine—Crohn's disease	0.000787	0.00521	CcSEcCtD
Losartan—AGTR1—lymph node—Crohn's disease	0.000784	0.0128	CbGeAlD
Losartan—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000781	0.00518	CcSEcCtD
Losartan—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00076	0.00504	CcSEcCtD
Losartan—Pollakiuria—Mesalazine—Crohn's disease	0.000756	0.00501	CcSEcCtD
Losartan—Agranulocytosis—Azathioprine—Crohn's disease	0.000747	0.00495	CcSEcCtD
Losartan—Photosensitivity reaction—Mesalazine—Crohn's disease	0.000747	0.00495	CcSEcCtD
Losartan—Decreased appetite—Mercaptopurine—Crohn's disease	0.000745	0.00494	CcSEcCtD
Losartan—Weight increased—Mesalazine—Crohn's disease	0.000744	0.00493	CcSEcCtD
Losartan—Pneumonia—Mesalazine—Crohn's disease	0.000734	0.00486	CcSEcCtD
Losartan—Cataract—Prednisone—Crohn's disease	0.000725	0.0048	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000723	0.00479	CcSEcCtD
Losartan—Renal failure—Mesalazine—Crohn's disease	0.000717	0.00475	CcSEcCtD
Losartan—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000715	0.00474	CcSEcCtD
Losartan—Jaundice—Mesalazine—Crohn's disease	0.000711	0.00471	CcSEcCtD
Losartan—Urinary tract infection—Mesalazine—Crohn's disease	0.000709	0.0047	CcSEcCtD
Losartan—Conjunctivitis—Mesalazine—Crohn's disease	0.000709	0.0047	CcSEcCtD
Losartan—Vasculitis—Prednisone—Crohn's disease	0.000707	0.00468	CcSEcCtD
Losartan—Sweating—Mesalazine—Crohn's disease	0.000699	0.00463	CcSEcCtD
Losartan—CYP1A2—digestive system—Crohn's disease	0.000696	0.0113	CbGeAlD
Losartan—Epistaxis—Mesalazine—Crohn's disease	0.000688	0.00456	CcSEcCtD
Losartan—Sinusitis—Mesalazine—Crohn's disease	0.000684	0.00453	CcSEcCtD
Losartan—Agranulocytosis—Mesalazine—Crohn's disease	0.000681	0.00451	CcSEcCtD
Losartan—Erythema multiforme—Azathioprine—Crohn's disease	0.00068	0.0045	CcSEcCtD
Losartan—Body temperature increased—Mercaptopurine—Crohn's disease	0.000677	0.00449	CcSEcCtD
Losartan—CYP3A5—digestive system—Crohn's disease	0.000672	0.0109	CbGeAlD
Losartan—CYP2C9—digestive system—Crohn's disease	0.000661	0.0108	CbGeAlD
Losartan—Skin exfoliation—Prednisone—Crohn's disease	0.000659	0.00436	CcSEcCtD
Losartan—Rhinitis—Mesalazine—Crohn's disease	0.000656	0.00435	CcSEcCtD
Losartan—Hepatitis—Mesalazine—Crohn's disease	0.000655	0.00434	CcSEcCtD
Losartan—Pharyngitis—Mesalazine—Crohn's disease	0.00065	0.00431	CcSEcCtD
Losartan—Arrhythmia—Azathioprine—Crohn's disease	0.000642	0.00426	CcSEcCtD
Losartan—Alopecia—Azathioprine—Crohn's disease	0.000635	0.00421	CcSEcCtD
Losartan—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000631	0.00418	CcSEcCtD
Losartan—Ecchymosis—Prednisone—Crohn's disease	0.000624	0.00413	CcSEcCtD
Losartan—Erythema multiforme—Mesalazine—Crohn's disease	0.000619	0.0041	CcSEcCtD
Losartan—Pulmonary oedema—Prednisone—Crohn's disease	0.000614	0.00407	CcSEcCtD
Losartan—Tinnitus—Mesalazine—Crohn's disease	0.00061	0.00405	CcSEcCtD
Losartan—ALB—lymph node—Crohn's disease	0.000605	0.00986	CbGeAlD
Losartan—Angiopathy—Mesalazine—Crohn's disease	0.000594	0.00394	CcSEcCtD
Losartan—Diarrhoea—Mercaptopurine—Crohn's disease	0.000586	0.00389	CcSEcCtD
Losartan—Ill-defined disorder—Azathioprine—Crohn's disease	0.000581	0.00385	CcSEcCtD
Losartan—ACE—lymph node—Crohn's disease	0.000579	0.00943	CbGeAlD
Losartan—Alopecia—Mesalazine—Crohn's disease	0.000579	0.00383	CcSEcCtD
Losartan—Anaemia—Azathioprine—Crohn's disease	0.000578	0.00383	CcSEcCtD
Losartan—Diabetes mellitus—Prednisone—Crohn's disease	0.000576	0.00382	CcSEcCtD
Losartan—Erythema—Mesalazine—Crohn's disease	0.00057	0.00378	CcSEcCtD
Losartan—Malaise—Azathioprine—Crohn's disease	0.000564	0.00374	CcSEcCtD
Losartan—Flatulence—Mesalazine—Crohn's disease	0.000562	0.00372	CcSEcCtD
Losartan—Leukopenia—Azathioprine—Crohn's disease	0.00056	0.00371	CcSEcCtD
Losartan—Vascular purpura—Prednisone—Crohn's disease	0.00056	0.00371	CcSEcCtD
Losartan—Tension—Mesalazine—Crohn's disease	0.000559	0.00371	CcSEcCtD
Losartan—Dysgeusia—Mesalazine—Crohn's disease	0.000558	0.0037	CcSEcCtD
Losartan—Nervousness—Mesalazine—Crohn's disease	0.000554	0.00367	CcSEcCtD
Losartan—Back pain—Mesalazine—Crohn's disease	0.000551	0.00365	CcSEcCtD
Losartan—Muscle spasms—Mesalazine—Crohn's disease	0.000548	0.00363	CcSEcCtD
Losartan—Vomiting—Mercaptopurine—Crohn's disease	0.000545	0.00361	CcSEcCtD
Losartan—Injury—Prednisone—Crohn's disease	0.000545	0.00361	CcSEcCtD
Losartan—Rash—Mercaptopurine—Crohn's disease	0.00054	0.00358	CcSEcCtD
Losartan—Dermatitis—Mercaptopurine—Crohn's disease	0.00054	0.00358	CcSEcCtD
Losartan—Vision blurred—Mesalazine—Crohn's disease	0.000537	0.00356	CcSEcCtD
Losartan—Tremor—Mesalazine—Crohn's disease	0.000534	0.00354	CcSEcCtD
Losartan—Arthralgia—Azathioprine—Crohn's disease	0.000533	0.00353	CcSEcCtD
Losartan—Myalgia—Azathioprine—Crohn's disease	0.000533	0.00353	CcSEcCtD
Losartan—Ill-defined disorder—Mesalazine—Crohn's disease	0.000529	0.0035	CcSEcCtD
Losartan—Anaemia—Mesalazine—Crohn's disease	0.000527	0.00349	CcSEcCtD
Losartan—Discomfort—Azathioprine—Crohn's disease	0.000526	0.00349	CcSEcCtD
Losartan—Angioedema—Mesalazine—Crohn's disease	0.000521	0.00345	CcSEcCtD
Losartan—Purpura—Prednisone—Crohn's disease	0.00052	0.00344	CcSEcCtD
Losartan—Malaise—Mesalazine—Crohn's disease	0.000514	0.00341	CcSEcCtD
Losartan—Vertigo—Mesalazine—Crohn's disease	0.000512	0.00339	CcSEcCtD
Losartan—Syncope—Mesalazine—Crohn's disease	0.000511	0.00339	CcSEcCtD
Losartan—Leukopenia—Mesalazine—Crohn's disease	0.00051	0.00338	CcSEcCtD
Losartan—Nausea—Mercaptopurine—Crohn's disease	0.000509	0.00337	CcSEcCtD
Losartan—Infection—Azathioprine—Crohn's disease	0.000507	0.00336	CcSEcCtD
Losartan—CYP3A4—digestive system—Crohn's disease	0.000504	0.00821	CbGeAlD
Losartan—Palpitations—Mesalazine—Crohn's disease	0.000504	0.00334	CcSEcCtD
Losartan—Loss of consciousness—Mesalazine—Crohn's disease	0.000501	0.00332	CcSEcCtD
Losartan—Thrombocytopenia—Azathioprine—Crohn's disease	0.0005	0.00331	CcSEcCtD
Losartan—Cough—Mesalazine—Crohn's disease	0.000497	0.0033	CcSEcCtD
Losartan—Chest pain—Mesalazine—Crohn's disease	0.000485	0.00322	CcSEcCtD
Losartan—Myalgia—Mesalazine—Crohn's disease	0.000485	0.00322	CcSEcCtD
Losartan—Arthralgia—Mesalazine—Crohn's disease	0.000485	0.00322	CcSEcCtD
Losartan—Anxiety—Mesalazine—Crohn's disease	0.000484	0.0032	CcSEcCtD
Losartan—Face oedema—Prednisone—Crohn's disease	0.000483	0.0032	CcSEcCtD
Losartan—Discomfort—Mesalazine—Crohn's disease	0.000479	0.00318	CcSEcCtD
Losartan—Hypotension—Azathioprine—Crohn's disease	0.000477	0.00316	CcSEcCtD
Losartan—Dry mouth—Mesalazine—Crohn's disease	0.000475	0.00315	CcSEcCtD
Losartan—ABCB1—epithelium—Crohn's disease	0.000469	0.00764	CbGeAlD
Losartan—Confusional state—Mesalazine—Crohn's disease	0.000469	0.00311	CcSEcCtD
Losartan—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000465	0.00308	CcSEcCtD
Losartan—Anaphylactic shock—Mesalazine—Crohn's disease	0.000465	0.00308	CcSEcCtD
Losartan—Oedema—Mesalazine—Crohn's disease	0.000465	0.00308	CcSEcCtD
Losartan—Infection—Mesalazine—Crohn's disease	0.000462	0.00306	CcSEcCtD
Losartan—Dry skin—Prednisone—Crohn's disease	0.000459	0.00304	CcSEcCtD
Losartan—Shock—Mesalazine—Crohn's disease	0.000458	0.00303	CcSEcCtD
Losartan—Nervous system disorder—Mesalazine—Crohn's disease	0.000456	0.00302	CcSEcCtD
Losartan—Thrombocytopenia—Mesalazine—Crohn's disease	0.000455	0.00302	CcSEcCtD
Losartan—Tachycardia—Mesalazine—Crohn's disease	0.000454	0.00301	CcSEcCtD
Losartan—Hyperhidrosis—Mesalazine—Crohn's disease	0.00045	0.00298	CcSEcCtD
Losartan—Anorexia—Mesalazine—Crohn's disease	0.000443	0.00294	CcSEcCtD
Losartan—Muscular weakness—Prednisone—Crohn's disease	0.000442	0.00293	CcSEcCtD
Losartan—Hypotension—Mesalazine—Crohn's disease	0.000435	0.00288	CcSEcCtD
Losartan—Pancreatitis—Prednisone—Crohn's disease	0.000424	0.00281	CcSEcCtD
Losartan—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000424	0.00281	CcSEcCtD
Losartan—Feeling abnormal—Azathioprine—Crohn's disease	0.000421	0.00279	CcSEcCtD
Losartan—Insomnia—Mesalazine—Crohn's disease	0.000421	0.00279	CcSEcCtD
Losartan—Paraesthesia—Mesalazine—Crohn's disease	0.000418	0.00277	CcSEcCtD
Losartan—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000418	0.00277	CcSEcCtD
Losartan—Dyspnoea—Mesalazine—Crohn's disease	0.000415	0.00275	CcSEcCtD
Losartan—Somnolence—Mesalazine—Crohn's disease	0.000414	0.00274	CcSEcCtD
Losartan—Dyspepsia—Mesalazine—Crohn's disease	0.000409	0.00271	CcSEcCtD
Losartan—ABCB1—mammalian vulva—Crohn's disease	0.000407	0.00663	CbGeAlD
Losartan—Decreased appetite—Mesalazine—Crohn's disease	0.000404	0.00268	CcSEcCtD
Losartan—Body temperature increased—Azathioprine—Crohn's disease	0.000404	0.00268	CcSEcCtD
Losartan—Abdominal pain—Azathioprine—Crohn's disease	0.000404	0.00268	CcSEcCtD
Losartan—Fatigue—Mesalazine—Crohn's disease	0.000401	0.00266	CcSEcCtD
Losartan—Erectile dysfunction—Prednisone—Crohn's disease	0.000399	0.00264	CcSEcCtD
Losartan—Pain—Mesalazine—Crohn's disease	0.000398	0.00264	CcSEcCtD
Losartan—Constipation—Mesalazine—Crohn's disease	0.000398	0.00264	CcSEcCtD
Losartan—Weight increased—Prednisone—Crohn's disease	0.000394	0.00261	CcSEcCtD
Losartan—Hyperglycaemia—Prednisone—Crohn's disease	0.00039	0.00259	CcSEcCtD
Losartan—Feeling abnormal—Mesalazine—Crohn's disease	0.000383	0.00254	CcSEcCtD
Losartan—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00038	0.00252	CcSEcCtD
Losartan—Neuropathy peripheral—Prednisone—Crohn's disease	0.000378	0.00251	CcSEcCtD
Losartan—Hypersensitivity—Azathioprine—Crohn's disease	0.000376	0.00249	CcSEcCtD
Losartan—Urticaria—Mesalazine—Crohn's disease	0.00037	0.00245	CcSEcCtD
Losartan—Body temperature increased—Mesalazine—Crohn's disease	0.000368	0.00244	CcSEcCtD
Losartan—Abdominal pain—Mesalazine—Crohn's disease	0.000368	0.00244	CcSEcCtD
Losartan—ABCB1—lymphoid tissue—Crohn's disease	0.000361	0.00589	CbGeAlD
Losartan—ABCB1—digestive system—Crohn's disease	0.000357	0.00581	CbGeAlD
Losartan—Diarrhoea—Azathioprine—Crohn's disease	0.000349	0.00232	CcSEcCtD
Losartan—Hypersensitivity—Mesalazine—Crohn's disease	0.000343	0.00227	CcSEcCtD
Losartan—Dizziness—Azathioprine—Crohn's disease	0.000338	0.00224	CcSEcCtD
Losartan—Asthenia—Mesalazine—Crohn's disease	0.000334	0.00221	CcSEcCtD
Losartan—Pruritus—Mesalazine—Crohn's disease	0.000329	0.00218	CcSEcCtD
Losartan—Vomiting—Azathioprine—Crohn's disease	0.000325	0.00215	CcSEcCtD
Losartan—Rash—Azathioprine—Crohn's disease	0.000322	0.00213	CcSEcCtD
Losartan—Dermatitis—Azathioprine—Crohn's disease	0.000322	0.00213	CcSEcCtD
Losartan—Flushing—Prednisone—Crohn's disease	0.000321	0.00213	CcSEcCtD
Losartan—Headache—Azathioprine—Crohn's disease	0.00032	0.00212	CcSEcCtD
Losartan—Diarrhoea—Mesalazine—Crohn's disease	0.000318	0.00211	CcSEcCtD
Losartan—Angiopathy—Prednisone—Crohn's disease	0.000314	0.00208	CcSEcCtD
Losartan—Arrhythmia—Prednisone—Crohn's disease	0.000309	0.00205	CcSEcCtD
Losartan—Dizziness—Mesalazine—Crohn's disease	0.000308	0.00204	CcSEcCtD
Losartan—Alopecia—Prednisone—Crohn's disease	0.000306	0.00203	CcSEcCtD
Losartan—Nausea—Azathioprine—Crohn's disease	0.000303	0.00201	CcSEcCtD
Losartan—Erythema—Prednisone—Crohn's disease	0.000302	0.002	CcSEcCtD
Losartan—Vomiting—Mesalazine—Crohn's disease	0.000296	0.00196	CcSEcCtD
Losartan—Rash—Mesalazine—Crohn's disease	0.000293	0.00194	CcSEcCtD
Losartan—Dermatitis—Mesalazine—Crohn's disease	0.000293	0.00194	CcSEcCtD
Losartan—Headache—Mesalazine—Crohn's disease	0.000291	0.00193	CcSEcCtD
Losartan—Vision blurred—Prednisone—Crohn's disease	0.000284	0.00188	CcSEcCtD
Losartan—Ill-defined disorder—Prednisone—Crohn's disease	0.00028	0.00185	CcSEcCtD
Losartan—Anaemia—Prednisone—Crohn's disease	0.000279	0.00185	CcSEcCtD
Losartan—Agitation—Prednisone—Crohn's disease	0.000277	0.00184	CcSEcCtD
Losartan—Nausea—Mesalazine—Crohn's disease	0.000276	0.00183	CcSEcCtD
Losartan—Angioedema—Prednisone—Crohn's disease	0.000276	0.00183	CcSEcCtD
Losartan—Malaise—Prednisone—Crohn's disease	0.000272	0.0018	CcSEcCtD
Losartan—Vertigo—Prednisone—Crohn's disease	0.000271	0.0018	CcSEcCtD
Losartan—Syncope—Prednisone—Crohn's disease	0.00027	0.00179	CcSEcCtD
Losartan—Loss of consciousness—Prednisone—Crohn's disease	0.000265	0.00176	CcSEcCtD
Losartan—Arthralgia—Prednisone—Crohn's disease	0.000257	0.0017	CcSEcCtD
Losartan—Myalgia—Prednisone—Crohn's disease	0.000257	0.0017	CcSEcCtD
Losartan—Anxiety—Prednisone—Crohn's disease	0.000256	0.0017	CcSEcCtD
Losartan—Discomfort—Prednisone—Crohn's disease	0.000254	0.00168	CcSEcCtD
Losartan—Oedema—Prednisone—Crohn's disease	0.000246	0.00163	CcSEcCtD
Losartan—Anaphylactic shock—Prednisone—Crohn's disease	0.000246	0.00163	CcSEcCtD
Losartan—Infection—Prednisone—Crohn's disease	0.000244	0.00162	CcSEcCtD
Losartan—Shock—Prednisone—Crohn's disease	0.000242	0.0016	CcSEcCtD
Losartan—Nervous system disorder—Prednisone—Crohn's disease	0.000241	0.0016	CcSEcCtD
Losartan—Tachycardia—Prednisone—Crohn's disease	0.00024	0.00159	CcSEcCtD
Losartan—Hyperhidrosis—Prednisone—Crohn's disease	0.000238	0.00158	CcSEcCtD
Losartan—Anorexia—Prednisone—Crohn's disease	0.000235	0.00155	CcSEcCtD
Losartan—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000224	0.00149	CcSEcCtD
Losartan—Insomnia—Prednisone—Crohn's disease	0.000223	0.00148	CcSEcCtD
Losartan—Paraesthesia—Prednisone—Crohn's disease	0.000221	0.00146	CcSEcCtD
Losartan—Dyspepsia—Prednisone—Crohn's disease	0.000217	0.00144	CcSEcCtD
Losartan—Decreased appetite—Prednisone—Crohn's disease	0.000214	0.00142	CcSEcCtD
Losartan—Fatigue—Prednisone—Crohn's disease	0.000212	0.00141	CcSEcCtD
Losartan—Constipation—Prednisone—Crohn's disease	0.00021	0.00139	CcSEcCtD
Losartan—ABCB1—lymph node—Crohn's disease	0.000204	0.00332	CbGeAlD
Losartan—Feeling abnormal—Prednisone—Crohn's disease	0.000203	0.00134	CcSEcCtD
Losartan—Gastrointestinal pain—Prednisone—Crohn's disease	0.000201	0.00133	CcSEcCtD
Losartan—Urticaria—Prednisone—Crohn's disease	0.000196	0.0013	CcSEcCtD
Losartan—Abdominal pain—Prednisone—Crohn's disease	0.000195	0.00129	CcSEcCtD
Losartan—Body temperature increased—Prednisone—Crohn's disease	0.000195	0.00129	CcSEcCtD
Losartan—Hypersensitivity—Prednisone—Crohn's disease	0.000181	0.0012	CcSEcCtD
Losartan—Asthenia—Prednisone—Crohn's disease	0.000177	0.00117	CcSEcCtD
Losartan—Pruritus—Prednisone—Crohn's disease	0.000174	0.00115	CcSEcCtD
Losartan—Diarrhoea—Prednisone—Crohn's disease	0.000168	0.00112	CcSEcCtD
Losartan—Dizziness—Prednisone—Crohn's disease	0.000163	0.00108	CcSEcCtD
Losartan—Vomiting—Prednisone—Crohn's disease	0.000156	0.00104	CcSEcCtD
Losartan—Rash—Prednisone—Crohn's disease	0.000155	0.00103	CcSEcCtD
Losartan—Dermatitis—Prednisone—Crohn's disease	0.000155	0.00103	CcSEcCtD
Losartan—Headache—Prednisone—Crohn's disease	0.000154	0.00102	CcSEcCtD
Losartan—Nausea—Prednisone—Crohn's disease	0.000146	0.000969	CcSEcCtD
Losartan—CYP2C19—Metapathway biotransformation—GPX4—Crohn's disease	0.000136	0.00109	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CCR9—Crohn's disease	0.000136	0.00109	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000135	0.00108	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000135	0.00108	CbGpPWpGaD
Losartan—SLC22A12—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000135	0.00108	CbGpPWpGaD
Losartan—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000133	0.00107	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—CRP—Crohn's disease	0.000133	0.00106	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—F5—Crohn's disease	0.000127	0.00102	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—GPR65—Crohn's disease	0.000126	0.00101	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000125	0.001	CbGpPWpGaD
Losartan—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	0.000124	0.000995	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—ACKR2—Crohn's disease	0.000122	0.000978	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—ICAM1—Crohn's disease	0.000122	0.000978	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—IL10—Crohn's disease	0.00012	0.00096	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PLA2G4F—Crohn's disease	0.000117	0.000939	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MLN—Crohn's disease	0.000116	0.000928	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000115	0.000922	CbGpPWpGaD
Losartan—ALB—Vitamin B12 Metabolism—IFNG—Crohn's disease	0.000114	0.000914	CbGpPWpGaD
Losartan—CYP2C8—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000112	0.000896	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000111	0.000886	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PLA2G4F—Crohn's disease	0.000111	0.000885	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.00011	0.000885	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00011	0.00088	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	0.000107	0.000856	CbGpPWpGaD
Losartan—ALB—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000107	0.000855	CbGpPWpGaD
Losartan—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	0.000106	0.00085	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TAGAP—Crohn's disease	0.000106	0.000848	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—CRP—Crohn's disease	0.000105	0.000845	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000104	0.000836	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000103	0.000828	CbGpPWpGaD
Losartan—ALB—Vitamin B12 Metabolism—IL1B—Crohn's disease	0.000102	0.000816	CbGpPWpGaD
Losartan—CYP2C19—Arachidonic acid metabolism—PTGS2—Crohn's disease	9.98e-05	0.000799	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—MTMR3—Crohn's disease	9.97e-05	0.000799	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PLA2G4F—Crohn's disease	9.97e-05	0.000799	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CCR6—Crohn's disease	9.91e-05	0.000794	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—ICAM1—Crohn's disease	9.7e-05	0.000777	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	9.58e-05	0.000767	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	9.53e-05	0.000763	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—GCKR—Crohn's disease	9.5e-05	0.000761	CbGpPWpGaD
Losartan—ALB—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	9.44e-05	0.000756	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—MTMR3—Crohn's disease	9.4e-05	0.000753	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—IFNG—Crohn's disease	9.29e-05	0.000744	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—RSPO3—Crohn's disease	9.26e-05	0.000741	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	9.23e-05	0.000739	CbGpPWpGaD
Losartan—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	9.1e-05	0.000729	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—ALB—Crohn's disease	9.09e-05	0.000728	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CCR6—Crohn's disease	9e-05	0.000721	CbGpPWpGaD
Losartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—Crohn's disease	8.85e-05	0.000709	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SEL1L—Crohn's disease	8.77e-05	0.000703	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—PTGER4—Crohn's disease	8.72e-05	0.000699	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	8.67e-05	0.000695	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	8.55e-05	0.000685	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—MTMR3—Crohn's disease	8.48e-05	0.000679	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.39e-05	0.000672	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	8.31e-05	0.000666	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—IL1B—Crohn's disease	8.28e-05	0.000664	CbGpPWpGaD
Losartan—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	8.19e-05	0.000656	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	8.15e-05	0.000653	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PLA2G4F—Crohn's disease	8.1e-05	0.000649	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	8.1e-05	0.000649	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCR9—Crohn's disease	8.03e-05	0.000643	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—PTGS2—Crohn's disease	7.95e-05	0.000637	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—PTGER4—Crohn's disease	7.92e-05	0.000635	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	7.8e-05	0.000625	CbGpPWpGaD
Losartan—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	7.78e-05	0.000623	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—FADS1—Crohn's disease	7.77e-05	0.000622	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	7.73e-05	0.00062	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	7.7e-05	0.000617	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	7.7e-05	0.000617	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—IL3—Crohn's disease	7.64e-05	0.000612	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	7.52e-05	0.000603	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—GPR65—Crohn's disease	7.46e-05	0.000598	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—IL3—Crohn's disease	7.43e-05	0.000595	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PLA2G4F—Crohn's disease	7.42e-05	0.000595	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	7.42e-05	0.000594	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	7.39e-05	0.000592	CbGpPWpGaD
Losartan—ALB—Vitamin B12 Metabolism—TNF—Crohn's disease	7.39e-05	0.000592	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—IFNG—Crohn's disease	7.38e-05	0.000591	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—FADS1—Crohn's disease	7.32e-05	0.000586	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—GPX4—Crohn's disease	7.27e-05	0.000583	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	7.27e-05	0.000582	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—RASGRP1—Crohn's disease	7.19e-05	0.000576	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—PTGS2—Crohn's disease	7.07e-05	0.000567	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—IFNG—Crohn's disease	7.05e-05	0.000564	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—GCKR—Crohn's disease	7.02e-05	0.000563	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—MTMR3—Crohn's disease	6.89e-05	0.000552	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—GPX4—Crohn's disease	6.85e-05	0.000549	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—IL3—Crohn's disease	6.75e-05	0.000541	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	6.75e-05	0.000541	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	6.75e-05	0.000541	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	6.66e-05	0.000534	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	6.63e-05	0.000531	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—GCKR—Crohn's disease	6.62e-05	0.00053	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—FADS1—Crohn's disease	6.6e-05	0.000529	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—IL1B—Crohn's disease	6.58e-05	0.000527	CbGpPWpGaD
Losartan—ALB—Hemostasis—F5—Crohn's disease	6.57e-05	0.000526	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	6.55e-05	0.000525	CbGpPWpGaD
Losartan—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	6.54e-05	0.000524	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—RASGRP1—Crohn's disease	6.53e-05	0.000523	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	6.35e-05	0.000508	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—MTMR3—Crohn's disease	6.31e-05	0.000506	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	6.31e-05	0.000505	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—IL1B—Crohn's disease	6.29e-05	0.000504	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—GPX4—Crohn's disease	6.18e-05	0.000495	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—TNF—Crohn's disease	6.01e-05	0.000481	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—GCKR—Crohn's disease	5.97e-05	0.000479	CbGpPWpGaD
Losartan—ALB—Vitamin B12 Metabolism—IL6—Crohn's disease	5.96e-05	0.000478	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—CXCL8—Crohn's disease	5.96e-05	0.000477	CbGpPWpGaD
Losartan—SLCO1B1—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.95e-05	0.000476	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.94e-05	0.000476	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.91e-05	0.000473	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	5.67e-05	0.000454	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.66e-05	0.000454	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—CXCL8—Crohn's disease	5.65e-05	0.000453	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	5.63e-05	0.000451	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	5.61e-05	0.00045	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	5.61e-05	0.00045	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.43e-05	0.000435	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—FADS1—Crohn's disease	5.37e-05	0.00043	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	5.35e-05	0.000429	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCR6—Crohn's disease	5.32e-05	0.000426	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.3e-05	0.000425	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—IL2RA—Crohn's disease	5.21e-05	0.000417	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.16e-05	0.000414	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—GPX4—Crohn's disease	5.03e-05	0.000403	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	4.93e-05	0.000395	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—FADS1—Crohn's disease	4.92e-05	0.000394	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—GCKR—Crohn's disease	4.85e-05	0.000389	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—IL6—Crohn's disease	4.85e-05	0.000389	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.84e-05	0.000387	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—RBX1—Crohn's disease	4.81e-05	0.000385	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.8e-05	0.000384	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	4.77e-05	0.000382	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.75e-05	0.000381	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.73e-05	0.000379	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—IL2RA—Crohn's disease	4.73e-05	0.000379	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PTGER4—Crohn's disease	4.68e-05	0.000375	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—GPX4—Crohn's disease	4.61e-05	0.000369	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—TNF—Crohn's disease	4.56e-05	0.000365	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—ALB—Crohn's disease	4.5e-05	0.00036	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—GCKR—Crohn's disease	4.45e-05	0.000356	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.41e-05	0.000354	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	4.27e-05	0.000342	CbGpPWpGaD
Losartan—ALB—Metabolism—PLA2G4F—Crohn's disease	4.24e-05	0.00034	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—UBE2D1—Crohn's disease	4.22e-05	0.000338	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.2e-05	0.000337	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—MTMR3—Crohn's disease	4.19e-05	0.000336	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.14e-05	0.000332	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.13e-05	0.000331	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—RIPK2—Crohn's disease	4.09e-05	0.000327	CbGpPWpGaD
Losartan—ALB—Hemostasis—ITGA4—Crohn's disease	4.04e-05	0.000324	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL3—Crohn's disease	3.99e-05	0.000319	CbGpPWpGaD
Losartan—ALB—Hemostasis—IL3—Crohn's disease	3.94e-05	0.000316	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—RASGRP1—Crohn's disease	3.86e-05	0.000309	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	3.85e-05	0.000309	CbGpPWpGaD
Losartan—ALB—Hemostasis—RASGRP1—Crohn's disease	3.81e-05	0.000305	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	3.81e-05	0.000305	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PLA2G4F—Crohn's disease	3.72e-05	0.000298	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—MTMR3—Crohn's disease	3.63e-05	0.000291	CbGpPWpGaD
Losartan—ALB—Metabolism—MTMR3—Crohn's disease	3.61e-05	0.000289	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	3.6e-05	0.000288	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—JAK2—Crohn's disease	3.5e-05	0.00028	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SOCS1—Crohn's disease	3.49e-05	0.00028	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	3.47e-05	0.000278	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	3.33e-05	0.000267	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—TYK2—Crohn's disease	3.33e-05	0.000267	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	3.32e-05	0.000266	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—FADS1—Crohn's disease	3.26e-05	0.000261	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—MTMR3—Crohn's disease	3.24e-05	0.000259	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CXCL8—Crohn's disease	3.19e-05	0.000256	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.18e-05	0.000255	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—JAK2—Crohn's disease	3.18e-05	0.000255	CbGpPWpGaD
Losartan—ABCB1—Metabolism—MTMR3—Crohn's disease	3.16e-05	0.000253	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GPX4—Crohn's disease	3.06e-05	0.000245	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—ALB—Crohn's disease	3.02e-05	0.000242	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SMAD3—Crohn's disease	3.02e-05	0.000242	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	2.97e-05	0.000238	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—MTMR3—Crohn's disease	2.95e-05	0.000237	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GCKR—Crohn's disease	2.95e-05	0.000236	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CXCL8—Crohn's disease	2.9e-05	0.000232	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—FADS1—Crohn's disease	2.83e-05	0.000226	CbGpPWpGaD
Losartan—ALB—Metabolism—FADS1—Crohn's disease	2.81e-05	0.000225	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL2RA—Crohn's disease	2.79e-05	0.000224	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.78e-05	0.000223	CbGpPWpGaD
Losartan—ALB—Hemostasis—IL2RA—Crohn's disease	2.76e-05	0.000221	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GPX4—Crohn's disease	2.65e-05	0.000212	CbGpPWpGaD
Losartan—ALB—Metabolism—GPX4—Crohn's disease	2.63e-05	0.000211	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GCKR—Crohn's disease	2.56e-05	0.000205	CbGpPWpGaD
Losartan—ALB—Metabolism—GCKR—Crohn's disease	2.54e-05	0.000204	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—MTMR3—Crohn's disease	2.52e-05	0.000202	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—FADS1—Crohn's disease	2.52e-05	0.000202	CbGpPWpGaD
Losartan—ABCB1—Metabolism—FADS1—Crohn's disease	2.46e-05	0.000197	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GPX4—Crohn's disease	2.36e-05	0.000189	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GPX4—Crohn's disease	2.31e-05	0.000185	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—FADS1—Crohn's disease	2.3e-05	0.000184	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	2.29e-05	0.000183	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GCKR—Crohn's disease	2.28e-05	0.000183	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	2.25e-05	0.00018	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—ALB—Crohn's disease	2.24e-05	0.000179	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GCKR—Crohn's disease	2.23e-05	0.000178	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GPX4—Crohn's disease	2.15e-05	0.000173	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—ALB—Crohn's disease	2.11e-05	0.000169	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GCKR—Crohn's disease	2.08e-05	0.000167	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TYK2—Crohn's disease	1.97e-05	0.000158	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—FADS1—Crohn's disease	1.97e-05	0.000157	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PTGS2—Crohn's disease	1.96e-05	0.000157	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.95e-05	0.000156	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—ALB—Crohn's disease	1.9e-05	0.000152	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—JAK2—Crohn's disease	1.88e-05	0.00015	CbGpPWpGaD
Losartan—ALB—Hemostasis—JAK2—Crohn's disease	1.85e-05	0.000149	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PTGS2—Crohn's disease	1.84e-05	0.000148	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GPX4—Crohn's disease	1.84e-05	0.000147	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.83e-05	0.000146	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GCKR—Crohn's disease	1.78e-05	0.000142	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CXCL8—Crohn's disease	1.71e-05	0.000137	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PTGS2—Crohn's disease	1.66e-05	0.000133	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.63e-05	0.000131	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—IL6—Crohn's disease	1.63e-05	0.00013	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.6e-05	0.000128	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.59e-05	0.000127	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—ALB—Crohn's disease	1.54e-05	0.000124	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—FADS1—Crohn's disease	1.52e-05	0.000122	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.51e-05	0.000121	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.49e-05	0.000119	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.43e-05	0.000114	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GPX4—Crohn's disease	1.42e-05	0.000114	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ALB—Crohn's disease	1.42e-05	0.000113	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—STAT3—Crohn's disease	1.38e-05	0.00011	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GCKR—Crohn's disease	1.37e-05	0.00011	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTGS2—Crohn's disease	1.35e-05	0.000108	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.3e-05	0.000104	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.27e-05	0.000102	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTGS2—Crohn's disease	1.24e-05	9.92e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.11e-05	8.9e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL6—Crohn's disease	9.62e-06	7.71e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ALB—Crohn's disease	9.39e-06	7.52e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTGS2—Crohn's disease	8.22e-06	6.58e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ALB—Crohn's disease	8.13e-06	6.52e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ALB—Crohn's disease	7.26e-06	5.82e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTGS2—Crohn's disease	7.12e-06	5.7e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ALB—Crohn's disease	7.09e-06	5.68e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PTGS2—Crohn's disease	7.08e-06	5.67e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ALB—Crohn's disease	6.62e-06	5.3e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTGS2—Crohn's disease	6.35e-06	5.09e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTGS2—Crohn's disease	6.2e-06	4.97e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTGS2—Crohn's disease	5.79e-06	4.64e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ALB—Crohn's disease	5.66e-06	4.53e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTGS2—Crohn's disease	4.95e-06	3.96e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALB—Crohn's disease	4.37e-06	3.5e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTGS2—Crohn's disease	3.82e-06	3.06e-05	CbGpPWpGaD
